Global News Feed
Home
Bookmarks
Preferences
World
Extract
Custom
Fetch
Install
Total
Unread
Saved
More
Preferences
Custom News
Fetch News
Install App
Home
Saved
World
Extract
More
Prev
Back to News
Next
AstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal
โ
Source:
Reuters
Category:
General
Region:
General
Published:
August 03, 2026 at 16:48
๐ Summary
AstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal Reuters
๐ Read Full Article at Reuters
โจ Extract Article
๐ค Share
๐ท๏ธ Keywords:
astrazeneca
investors
balk
prospect
billion
bristol
myers
pharma
deal
reuters
๐ฌ Social Media Posts
๐ Refetch Posts
Searching social media for related posts...
Click "Fetch Related Posts" to find social media discussions about this article
๐ฐ Related Articles
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says
Reuters
ยท
Aug 02
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Reuters
ยท
Aug 05
AstraZeneca to invest over $1 billion in Massachusetts, boost workforce
Reuters
ยท
Oct 05
Dollar wobbles as investors balk at US Treasury's rescue efforts
Reuters
ยท
Aug 21
Previous Article
Next Article